Antimalarial Drugs Market

Antimalarial Drugs Market Size, Share, Growth Analysis, By drug class(Global antimalarial drugs industry share from the aryl aminoalcohol compounds segment might grow at a considerable pace by 2032. The number of people suffering from malaria across the world is increasing every year. About 241 million malaria cases were registered across the globe in 2022, with the WHO Africa region continuing to account for a large share of the disease burden. This will encourage people to take antimalarial drugs to prevent the disease infection. With regards to route of administration, antimalarial drugs market value from the oral segment is expected to increase at a significant rate by 2032. There are many advantages associated with this route of administration, such as better patient compliance), By application(The treatment segment is expected to capture a sizeable share of antimalarial drugs market by 2032. Malaria treatments depend on many factors including the species of malaria parasite, intensity of the disease, and the country/region in which the patient contracted the infection. Increasing global mortality rate from malaria might require people to receive proper medication to treat the disease effectively, thereby propelling the market growth.) - Industry Forecast 2024-2031


Report ID: UCMIG35I2258 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Antimalarial Drugs Market Competitive Landscape

To understand the competitive landscape, we are analyzing key Antimalarial Drugs Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Antimalarial Drugs Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

  • :
  • Cipla
  • Ipca Laboratories
  • Mylan
  • Zydus Cadila
  • GlaxoSmithKline
  • Strides Pharma Science Limited
  • Teva Pharmaceutical
  • F. Hoffmann-La Roche Ltd
  • Novartis
  • Lincoln Pharmaceuticals
  • Bayer
  • Alliance Pharma
  • Glenmark Pharmaceuticals.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Antimalarial Drugs was estimated to be valued at US$ XX Mn in 2021.

The Antimalarial Drugs Market is estimated to grow at a CAGR of XX% by 2028.

The Antimalarial Drugs Market is segmented on the basis of drug class, application.

Based on region, the Antimalarial Drugs Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Antimalarial Drugs Market are :, Cipla, Ipca Laboratories, Mylan, Zydus Cadila, GlaxoSmithKline, Strides Pharma Science Limited, Teva Pharmaceutical, F. Hoffmann-La Roche Ltd, Novartis, Lincoln Pharmaceuticals, Bayer, Alliance Pharma, Glenmark Pharmaceuticals..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Antimalarial Drugs Market

Report ID: UCMIG35I2258

$5,300
BUY NOW GET FREE SAMPLE